Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Thoracic Oncology
  •  Surgical Oncology
  •  Chemotherapy and Radiotherapy
  •  Stomach Cancer
  •  Radiation Therapy
  •  Paediatric Cancers
  •  Endoscopy Methods
  •  Ovarian Cancer

Abstract

Citation: Clin Oncol. 2019;4(1):1676.DOI: 10.25107/2474-1663.1676

Tyrosine Kinase Inhibitors (TKIs) in the Treatment of Non-Small Cell Lung Cancer (NSCLC), Practical Pharmacological Aspects

Alexandru C Grigorescu and Teodorescu Laura Mihaela

Department of Medical Oncology, The Oncological Institute of Bucharest, Romania
V Babes Diagnostic and Treatment Center, Romania

*Correspondance to: Alexandru C Grigorescu 

 PDF  Full Text Case Report | Open Access

Abstract:

Tyrosine Kinase Inhibitors are new drugs developed in the last decade. For Non-Small Cell Lung Cancer this drug brought more hope for patients with this disease. Also TKIs are better tolerated then chemotherapy. The efficacy of TKIs is dependent of the presence of Epidermal Grows Factor Receptor gene mutation. This mutation account for about 9% of patients with lung cancer in Europe. This short review try to give the minimal knowledge to clinicians, especially medical oncologists, about mechanism of action, pharmacokinetics of TKIs used in the treatment NSCLC.

Keywords:

Tyrosine Kinase Inhibitors (TKI); Non-small cell lung cancer; Pharmacokinetics aspects

Cite the Article:

Grigorescu AC, Mihaela TL. Tyrosine Kinase Inhibitors (TKIs) in the Treatment of Non-Small Cell Lung Cancer (NSCLC), Practical Pharmacological Aspects. Clin Oncol. 2019;4:1676.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Long-Term Follow-Up of Children Treated for Acute Leukemia Focusing on Development of Malignant and Non-Malignant Neoplasms
 Abstract  PDF  Full Text
Application of First-Line Steady-State Mobilization vs. Conventional Chemotherapy Mobilization for Peripheral Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients
 Abstract  PDF  Full Text
View More...